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Enzymes that hydrolyze GTP are currently in the spotlight, due to their molecular switch mechanism that
controls many cellular processes. One of the best-known classes of these enzymes are small GTPases such
as members of the Ras superfamily, which catalyze the hydrolysis of the c-phosphate bond in GTP. In
addition, the availability of an increasing number of crystal structures of translational GTPases such as
EF-Tu and EF-G have made it possible to probe the molecular details of GTP hydrolysis on the ribosome.
However, despite a wealth of biochemical, structural and computational data, the way in which GTP
hydrolysis is activated and regulated is still a controversial topic and well-designed simulations can play
an important role in resolving and rationalizing the experimental data. In this review, we discuss the con-
tributions of computational biology to our understanding of GTP hydrolysis on the ribosome and in small
GTPases.
 2015 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
GTPases are conserved regulators of cell motility, polarity, adhe-
sion, cytoskeletal organization, proliferation and apoptosis [1–3].
They forma large family of hydrolytic enzymes that can be classiﬁed
into a number of distinct subgroups: heterotrimeric G-proteins
(involved in hormonal and sensory signals), translational GTPases
(involved in ribosomal protein synthesis), members of the SPR/SR
family (involved in translocating peptides into the endoplasmic
reticulum), tubulins and cytoskeletal motor GTPases, and mono-
meric GTPases such as the Ras superfamily (which are responsible
for signal transduction cascades and motility) [4]. The primary bio-
chemical function of these enzymes is to catalyze the conversion of
GTP to GDP and inorganic phosphate (Pi) [5].
The most extensively studied class of small GTPases are by far
the members of the Ras superfamily [6]. Small GTPases are 20–
30 kDa proteins that function as molecular switches in numerous
cellular functions [7]. These are, in turn, divided into ﬁve subfami-
lies (Ras, Rho, Rab, Arf and Ran) that share a common fold. In
GTPases such as Ras, GTP binding and hydrolysis typically leads
to conformational transitions, such that these enzymes display a
GDP bound ‘‘OFF’’ state, an open state, and a GTP bound ‘‘ON’’ state
[8]. ‘‘ON’’ and ‘‘OFF’’ state regulation can be controlled by mecha-
nisms such as switches (Ras and homologs), clocks (heterotrimeric
G-proteins and subunits) and sensors (elongation factors such asEF-Tu and EF-G). In some G-proteins such as the Ras proteins
and trGTPases such as EF-Tu,1 this activation is also regulated by
guanine nucleotide exchange factors (GEFs) [9,10], which activate
the enzyme by facilitating the exchange of GDP to GTP.
Speciﬁcally, GEFs catalyze the release of the bound GDP, which is
replaced by abundant cellular GTP [11] (Fig. 1). In the activated state
G-proteins (also known as guanine nucleotide-binding proteins –
GNBPs) interact with and activate downstream targets (effectors),
which in turn trigger cellular responses [12,13]. GTP hydrolysis
returns GNBPs to their inactive state, thereby terminating down-
stream signaling. The switch between the ‘‘OFF’’ and ‘‘ON’’ states is
activated by the binding of GTPase-activating proteins (GAPs)
[8,11]. The active and inactive forms differ in the presence or
absence of the c-phosphate on the nucleotide, which is reﬂected in
considerable conformational differences in regions that contact this
terminal phosphate in the GTP-bound form [14].
In parallel to the ongoing interest in Ras GTPases, the recent
availability of an increasing number of crystal structures of trans-
lational GTPases such as elongation factors thermo unstable
(EF-Tu) and G (EF-G) [15–24] has led to an explosion of interest
in trying to understand the mechanisms of GTP hydrolysis on the
ribosome [20,25–38]. Speciﬁcally, translation can be roughly
divided into four phases: (i) initiation, where the ribosome binds
to the messenger RNA, (ii) elongation cycles, where new aminoguanine
ibosome
.n
re
Fig. 1. The GTP? GDP cycle of small GTPases such as Ras. GDP-bound Ras (in its
‘‘OFF’’ state) is activated by GEF (guanine nucleotide-exchange factor), which
facilitates the conversion of GDP to GTP (yielding the ‘‘ON’’ state of Ras).
Complexation with GTPase-activating protein (GAP) in turn activates Ras for GTP
hydrolysis.
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termination, where the newly synthesized polypeptide is released
from the ribosome, and, ﬁnally, (iv) recycling, where the ribosomal
subunits dissociate and become ready to re-initiate the cycle by
binding to a new mRNA. GTP hydrolysis is an essential part of all
the steps mentioned above and these biologically crucial GTP
hydrolysis reactions are catalyzed by a family of auxiliary proteins
factors, referred to as the translational GTPases (trGTPases)
[4,30,31,38]. Of these enzymes, the most mechanistically studied
is EF-Tu [20,25–29,31–35,37]. Its biological role lies in the correct
delivery of aminoacyl-tRNA at the A (aminoacyl) site of the ribo-
some. EF-Tu forms a ternary complex with aminoacyl-tRNAs and
GTP that bind to the ribosome [39] (Fig. 2). Correct codon–antico-
don recognition between the tRNA and the mRNA leads to a signiﬁ-
cant increase in the GTPase activity of EF-Tu by a factor of 105 [40].
Inorganic phosphate is released slowly after the hydrolysis [41]
and release of the EF-Tu:GDP complex from the ribosome results
in tRNA accommodation, which enables the correct conformation
for the peptide bond formation reaction to take place [42,43].
Another rather unique translational GTPase that facilitates
translocation (i.e. relocation of the tRNAs from the A and P (pep-
tidyl) sites to the P and E (exit) sites respectively, as well as the
relative movement of mRNA to the ribosome by three bases) is
EF-G [44–46]. This enzyme behaves both as a molecular switch
and as a motor protein [47]. Its binding to the ribosome after the
new peptide bond has been formed induces an inter-subunit rota-
tion that repositions the bound tRNAs into hybrid A/P and P/E sites
[48–50]. GTP hydrolysis takes place very quickly after binding [51],
followed by the completion of the translocation. The inorganic
phosphoric group remains bound and its release is linked to the
completion of the translocation [52]. Another unique characteristic
of this elongation factor is the absence of a GEF, as the afﬁnities for
GTP and GDP are similar and the exchange happens spontaneously
[53]. EF-G also participates in the recycling phase, facilitating the
dissociation of the ribosome recycling factor (RRF) from the ribo-
some [54]. Release factor 3 (RF3) is a GTPase participating in the
termination. GTP hydrolysis promotes the dissociation of RF1 and
RF2 [55].
Note that there are many global similarities between the active
sites of both translational GTPases such as EF-Tu and EF-G [56], as
well as regulatory GTPases such as Ras [57–59] (Fig. 3). There has
been substantial experimental and (increasingly) computational
work on these systems, and yet the mechanisms of GTP hydrolysis,
in particular by translational GTPases on the ribosome, remain
controversial [20,29,32,37,60]. In this review, we will provide an
overview of the basic challenges with studying phosphoryl trans-
fer, as well as the speciﬁc challenges in interpreting experimental
and computational data on GTP hydrolysis in biological systems.We will present popular current mechanistic proposals and high-
light the role of theory in enhancing our molecular understanding
of GTP hydrolysis on the ribosome and in related biological
systems.Challenges in elucidating the mechanisms of GTP hydrolysis in
biological systems
Phosphoryl transfer plays a critical role in signaling, protein
synthesis and energy transduction, making it one of the most
important classes of chemical reactions in biology [61]. As a result
of this, many enzymes (phosphatases, kinases, mutases) have
evolved to catalyze this class of reactions [62], and they operate
via a range of different mechanisms and preferred environmental
conditions such as low or high pH. Additionally, some of these
enzymes utilize direct attack by water, others employ an
enzyme-derived nucleophile and others still use metal ions as a
catalytic tool [61,63]. Phosphorylation and dephosphorylation of
a protein by kinases and phosphatases can affect the function of
a protein in many ways: (i) by increasing or decreasing its biologi-
cal activity, (ii) by stabilizing it or marking it for breakdown, (iii) by
facilitating or inhibiting movement between subcellular compart-
ments, or (iv) by initiating or disrupting protein–protein interac-
tions [64]. Due to the wide range of different mechanisms that
can be used in such enzymes, a comprehensive picture of the
mechanism of enzyme-catalyzed phosphoryl transfer remains
elusive.
One of the biggest controversies in the study of phosphoryl
transfer reactions has been to distinguish between the precise
molecular mechanisms involved and the nature of the correspond-
ing transition states [61,63,65,66]. Speciﬁcally, the availability of
low-lying d-orbitals on the phosphorus atom opens the door to a
range of mechanistic possibilities, such that the mechanisms of
phosphate hydrolysis may occur by a range of different mechanis-
tic pathways (Fig. 4). In a fully associative mechanism (AN + DN,
Fig. 4A), nucleophilic attack occurs prior to the departure of the
leaving group, and the reaction proceeds via inversion of conﬁg-
uration at the phosphorus atom. In contrast, in a dissociative path-
way (DN + AN, Fig. 4B), leaving group departure precedes
nucleophilic attack and the reaction proceeds via a metaphosphate
intermediate. In addition to the aforementioned stepwise path-
ways which proceed with intermediate formation, the reaction
can also proceed via a concerted SN2-like ANDN pathway (Fig. 4C),
in which bond formation to the nucleophile and bond cleavage to
the leaving group occur in a single transition state. Such a transi-
tion state can be dissociative or associative in nature, depending
on the degree of bond formation to the incoming nucleophile and
bond cleavage to the departing leaving group.
There have been extensive experimental studies on the
hydrolysis of highly charged phosphate monoester dianions, as
well as ATP and GTP hydrolysis in aqueous solution [67,68]. The
experimental data would largely suggest a loose, dissociative tran-
sition state, based on a steep leaving group dependence of 1.23 in
the linear free energy relationship [69], experimentally measured
kinetic isotope effects [70], and a small, negative activation
entropy [71]. However, quantum chemical calculations and careful
theoretical analysis have suggested that the interpretation of the
experimental observables is not unambiguous, as multiple differ-
ent pathways can give rise to the same experimental observables
[66,72]. Additionally, we recently demonstrated that in the case
of phosphate monoester dianion hydrolysis, while there is a clear
leaving-group dependent mechanistic preference between tighter
(more associative) and looser (more dissociative) transition states,
the competition between the two pathways is very close, suggest-
ing that an enzyme could in principle use either as a solution to the
Fig. 2. Ternary complex of EF-Tu (red), aminoacyl-transfer RNA (aa-tRNA) in the A/T (violet), P and E sites (yellow and green respectively) as well as the non-hydrolyzable
GTP analog GCP. (A) The relative position in the ribosome, where the 30s RNA (pink) and 50s RNA (blue) of the small and large ribosomal subunit respectively are noted. The
two aa-tRNAs are distant before the GTP hydrolysis, allowing for the related proofreading mechanisms to take place. (B) A more detailed view of the EF-Tu site. The GTP
analog, P-loop can be observed in this ﬁgure, as well as the sarcin–ricin loop (SRL) of the 50s RNA. This ﬁgure was created using the high-resolution crystal structures provided
by Ref. [20] (PDB codes: 2XQD, 2XQE).
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competing pathways has been the result of substantial controversy
in the literature (for detailed discussion see e.g. Refs. [61,73] and
Refs. cited therein).
Another topic that has been a subject of much debate is the nat-
ure of nucleophile activation. That is, in principle, the attacking
water molecule could be activated either by general-base catalysis
by bulk solvent (Fig. 5A), by direct proton transfer to the basic non-
bridging oxygens of the phosphate (e.g. pKa of 6.5 for GTP [74],
Fig. 5B), or by proton transfer to the phosphate via one or more
intervening water molecules (Fig. 5C). It has also been argued that,
in the case of GTP hydrolysis by for instance Ras GTPase, no general
base may be needed at all [63], with no nucleophile deprotonation
at the transition state.
Clearly, such controversy with regard to even the mechanism of
uncatalyzed phosphate hydrolysis in aqueous solution is only
ampliﬁed when moving to biological systems and, as can be seen
from subsequent discussion, has also been greatly discussed in
the case of biological GTP hydrolysis. We will argue in this review
that careful theoretical calculations that reproduce all experimen-
tal observables in a meaningful way provide an important step to
resolving these controversies.
Probing the mechanism of GTP hydrolysis by Ras GTPase
Although the main focus of this review is on modeling GTP
hydrolysis on the ribosome, we will start our discussion by revising
a closely related GTPase, namely Ras GTPase. As can be seen from
Fig. 3 a side-by-side comparison of the active sites of the two
enzymes (using Escherichia coli numbering for the EFs) shows great
similarities [20,21,75,76]. Speciﬁcally, both EF-Tu and Ras harness
a catalytic magnesium ion that interacts with the non-bridging
oxygens of the GTP. Near the GTP, there are two important regions
that change conformation upon GTP hydrolysis. These are desig-
nated Switch I and II. In Ras, Switch I (also called the G2 domain,
residues 30–40) contains an important threonine residue (Thr
35) that interacts with the metal and a non-bridging oxygen of
the c-phosphate of GTP. Switch II, or the G3 domain (residues
60–76), contains a conserved glutamine (Gln61) that interacts with
the nucleophilic water molecule. In EF-Tu, Switch II (residues 80–
100 in E. coli variant) contains a conserved histidine residue
(His84 in the case of the E. coli variant) that is in the corresponding
position to Gln61 in Ras GTPase. Switch I (residues 40–62 in theE. coli variant) does not directly interact with the GTP, however,
Ile60 of Switch I and Val20 of the P loop prevent the interaction
of the Switch II residues with GTP prior to EF-Tu activation.
Due to its important role as a signaling protein [77] and its
propensity towards oncogenic mutations [78], Ras GTPase has
been studied extensively both experimentally and computationally
[72,76,79–88], and the insights obtained by computational work
on Ras form a basis for subsequent theoretical studies of GTP
hydrolysis on the ribosome by EF-Tu [33–35,37,89,90]. As dis-
cussed before, the Ras GTPase acts as a switch, were the ‘‘ON’’ state
corresponds to the GTP-bound and the ‘‘OFF’’ state to the GDP-
bound state. The transition between the states is achieved by bind-
ing of the GAP, which accelerates the rate of GTP hydrolysis up to
ﬁve orders of magnitude in relation to the free Ras enzyme [91].
Mutational studies have additionally shown that mutations at
positions 12, 13 or 61 lead to a drastic reduction in the rate of
GTP hydrolysis, leaving the enzyme in a ‘‘ON’’ state which can lead
to cancer [92]. More insight into this enzyme came from the
determination of the crystal structure of the free enzyme and of
the complex with GAP [76,79,80]. Analysis of these crystals
showed that a particular residue in the GAP protein (Arg789, also
known as ‘‘arginine ﬁnger’’) is of fundamental importance for TS
stabilization during GTP hydrolysis [76]. It also showed that
Gln61 interacts with a water molecule that is in a perfect position
for nucleophilic attack on the c-phosphate of the GTP molecule.
However, analysis of the crystals did not provide an easy rationale
for the effect of the oncogenic mutations, particularly of Gln61.
This began a long [82,90,93,94] (and ongoing [63,72,86,88,95])
debate about what the catalytic mechanism for this enzyme actu-
ally is.
Early studies proposed that Gln61 could act as a base by remov-
ing a proton from the nucleophilic water molecule [80] (Fig. 6A).
This hypothesis is based on Gln61 position in the crystal structures
(Fig. 3C), but also on the high degree of conservation of this residue
as well as mutational studies [96]. Arguments against Gln61 as a
general base were presented from several corners [72,81,82,86],
but the ﬁrst group to quantitatively examine this hypothesis
computationally were Langen and coworkers [81]. These authors
showed that a hypothetical proton transfer to Gln61 would have
very large barrier (larger than the corresponding reaction in
water). Subsequent studies showed that substitution of this resi-
due with a poorer base, more exactly the synthetic analog NGlu,
had little effect on the GTP hydrolysis rate [61].
Fig. 3. A comparison of the active sites of (A) EF-Tu and (B) EF-G in complex with
GCP (GTP analog) using E. coli numbering, as well as (C) the Ras–GAP complex, with
the nucleophilic water molecule highlighted in red, and the Mg2+ ion highlighted in
green (to show the interactions, we use GNP from PDB ID 1CTQ instead of GDP from
PDB ID 1WQ1). SRL denotes the sarcin–ricin loop, and GAP denotes the GTPase
activating protein, the relevant parts of which have been included in this ﬁgure.
These structures were obtained from [20,21,75,76] (PDB codes: 2XQD, 2XQE, 4JUW,
4JUX, 1CTQ, 1WQ1). Key active site residues and interaction distances (Å) have been
highlighted in this ﬁgure.
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the base to the nature of the TS structure (although there is still
debate about the nature of this deprotonation, see e.g. [34,63]).
Rather, the question then became whether the corresponding TS
for the GTP hydrolysis is associative or dissociative in nature.
Several groups [93,97–102] argued for a dissociative TS based onFTIR and Raman spectroscopic studies, which assign vibrational
modes between the Pc-O3non-bridge and Pb-O2non-bridge (the P-
Obridge vibrations are coupled to other bonds). However, FTIR stud-
ies [100] were unable to ﬁnd the metaphosphate intermediate
expected for a fully dissociative mechanism, leading to the pro-
posal that the reaction was concerted, but with a more pronounced
dissociative character. According to this hypothesis, the nature of
the base has little effect on catalysis since in a dissociative TS there
is little charge development in the nucleophile, so PT from water
would occur rather late (after the TS).
This discussion coincided with the growing body of evidence in
favor of an alternate substrate-as-base mechanism (Fig. 6B), which
is currently the most accepted mechanism for GTP hydrolysis by
Ras GTPase [33,81–83,103–107] and related enzymes
[33,34,37,89,94]. However, it was argued that such a mechanism
would not be possible because of the underlying assumption of
the dissociative nature of the TS, where protonation of an oxygen
of the c-phosphate would lead to TS destabilization and be highly
unfavorable [94]. In part to address this concerns, Klähn et al. [72],
used an ab initio quantum mechanics molecular mechanics free
energy perturbation (QM(ai)/MM-FEP) treatment and showed that
the relevant TS has an associative character in both water and
enzyme (Fig. 7). The shape of the potential energy surface is similar
in both the enzyme-catalyzed reaction and in the uncatalyzed
background reaction; however, in the enzyme, the TS has an even
more pronounced associative character. The calculated barrier to
the enzyme catalyzed reaction was 14 kcal/mol, in excellent agree-
ment with the experimental barrier of 16 kcal/mol [72].
It was furthermore argued that the origin of the oncogenicity of
mutation of Gln61 lies in its interaction with the L4 loop of Switch
Region II. That is, Warshel and coworkers [90,108] performed EVB
calculations on the RasGAP complex and showed that mutation of
Gln61 affects the conformation of this loop, destroying the catalyti-
cally favorable preorganized catalytic conﬁguration obtained by
binding of GAP to Ras. Again, although the focus of this review is
on GTP hydrolysis on the ribosome, the extensive work on
RasGTPase, as well as corresponding mechanistic controversies,
form a basis for much of the contemporary discussion about GTP
hydrolysis by EF-Tu and related enzymes.GTP hydrolysis on the ribosome by EF-Tu
Following from the introductory discussion about biological GTP
hydrolysis by Ras GTPase, the recent elucidation of an increasing
number of crystal structures of EF-Tu and EF-G in complex with
the ribosome [20–23]have led toanexplosionof interest in elucidat-
ing the molecular mechanism of activation and GTP hydrolysis in
these enzymes. As in other GTPases, the a- and b-phosphates of
the GTP/GDP molecule bind to a conserved motif called the phos-
phate-loop (P-loop) [4,109]. The c-phosphate and the Mg2+ ion
interact with two loops within the G-domain designated by Switch
loop I and Switch loop II, which undergo important conformational
changes uponGTP hydrolysis (Fig. 8) [84]. This second loop contains
a universally conserved PGH motif, which terminates with a his-
tidine residue (His84 in the case of E. coli EF-Tu) that has been pro-
posed to play a role as a general base for GTP hydrolysis (see
discussion below) This functional residue is common to all
GTPases, however it takes the form of a glutamine for other related
enzymes such as Ras GTPase [76]. As shown in Figs. 3B and 9, the
sidechain of this histidine interactswithboth the nucleophilicwater
molecule, and with A2662 of the sarcin–ricin loop (SRL) of the 23S
RNA [110]. Also, as with Gln61 in Ras GTPase [82], His84 has been
suggested to act as a conformational switch for a transition from
the inactive to active state for GTP hydrolysis. Speciﬁcally, in the
inactive state of the enzyme His84 is prevented from entering the
Fig. 4. A comparison of different possible mechanistic pathways for phosphate monoester hydrolysis. (A) A fully associative (AN + DN) mechanism, in which nucleophilic
attack precedes departure of the leaving group and the reaction proceeds via a pentavalent intermediate with inversion of conﬁguration at the phosphorous atom. a. (B) A
fully dissociative (DN + AN) pathway, in which leaving group cleavage precedes nucleophilic attack, and the reaction proceeds via a metaphosphate intermediate. (C) A
concerted SN2-like (ANDN) pathway, in which bond formation to the nucleophile and bond cleavage to the leaving group occur in a single transition state. Such a transition
state can be synchronous or asynchronous depending on the degree of bond formation to the incoming nucleophile and bond cleavage to the departing leaving group. A
hypothetical scenario involving hydroxide attack on protonated GTP has been shown here for simplicity, to avoid complications with describing the deprotonation of a water
nucleophile (see main text).
Fig. 5. Different plausible mechanisms for initial proton transfer during GTP hydrolysis in aqueous solution. In principle, the nucleophilic water molecule could be activated
either by: (A) general-base catalysis by bulk solvent. (B) Proton transfer to the basic non-bridging oxygen atoms of the phosphate. (C) Proton transfer to the phosphate via one
or more intervening water molecules.
Fig. 6. Different mechanistic hypothesis for GTP hydrolysis by Ras GTPase available in the literature. (A) A base-catalyzed mechanism in which the catalytic water molecule is
deprotonated by the carbonyl group of the Gln 61 sidechain, and (B) a substrate-assisted mechanism such as that shown in Fig. 5B. Note that a similar mechanism to that
shown in Fig. 5C has also been suggested in the literature (see discussion of different mechanistic options in Ref. [95]). For further details, see e.g. Ref. [61].
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Fig. 7. Potential energy surfaces and corresponding transition state structures for GTP hydrolysis in aqueous solution (A and B) and in catalyzed by the Ras–GAP complex (C
and D) (for aqueous solution, hydrolysis of the monomethyl pyrophosphate trianion was used as model). As can be seen, the background reaction is already associative in
nature in the presence of a metal ion, in agreement with the prediction of Ref. [126], and this becomes even more associative in the presence of the enzyme. Reprinted with
permission from Ref. [72].
Fig. 8. (A) Overall conformational change of the G-domain of EF-Tu when the ternary complex (tRNA:EF-Tu:GTP) binds to the ribosome. This structural change can be seen by
superimposing the tRNAs of the free ternary complex (PDB code 2C78 [19]) with that of the ribosome-bound complex (PDB codes: 2XQD, 2XQE [20]). (B) Active site of EF-Tu
during GTP hydrolysis as seen in the high-resolution crystal structure (green), and as computed by MD simulations during an initial pre-reaction state (magenta), an
intermediate rotated state (yellow) and the ﬁnal activated state (cyan). The sarcin–ricin loop (SRL, orange), His84, and Val20 and Ile60 (which form the hydrophobic gate) are
highlighted. Reprinted with permission from Ref. [37].
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[111,112]. Upon activation, when the correct codon–anticodon
complex is formed, His84 moves toward the active site. Interaction
with the SRL is critical for this activation step [20–23].
Again, as with Ras GTPase, due to its biological importance,
there has been substantial experimental [20,29,53,110,113,114]and more recently also computational [34,35,37,89,115] work on
this system. For example, the rate constants of EF-Tu-dependent
binding of Phe-tRNA to the A site of poly(U)-programmed E. coli
ribosomes have been measured by different research groups
[41,42,48,116,117]. In 1998, Pape et al. [40], using pre-steady state
kinetic experiments, determined for the ﬁrst time the complete
Fig. 9. MD structure of the EF-Tu catalytic center during GTP hydrolysis. Shown
here is the resulting reactant complex after pre-equilibrium proton transfer from
the catalytic water molecule to the c-phosphate. The resulting hydroxide ion is
stabilized by the backbone NH groups of His84 and Gly83, the side chains of His84
and Thr61, and the protonated c-phosphate itself. The Mg2+ ion is depicted as a
white sphere. Reprinted with permission from [37].
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the ribosome is rapid and readily reversible. This is followed by
codon recognition, which then induces the EF-Tu conformational
change and GTP hydrolysis. In this work, the conformational
change and GTP hydrolysis were grouped together (GTP hydrolysis
was proposed to occur instantly after the protein rearrangement).Fig. 10. Schematic overview of different states along the elongation path. (A) Simpliﬁed
GTP (yielding the A/T conformation) and its subsequent accommodation into the ribosom
rRNA bases A1492, A1493 and G530 (based on crystallographic work [114]), which deﬁn
binding to peptide bond formation, based on the experimental studies of Refs. [118,119]
[115].The measured rate constants at 20 C were 500 ± 100 s1 at
10 mMMg2+ concentration and 55 ± 15 s1 at 5 mMMg2+ concen-
tration, which would correspond to activation free energies of
13.5 and 14.8 kcal/mol respectively. The authors measured also
putative rates for the conformational change from the GTP to
GDP bound form (60 ± 20 s1), aa-tRNA accommodation and pep-
tide bond formation (7 ± 1 and 8 ± 1 s1, depending on the Mg2+
concentration) and dissociation of EF-Tu (3 ± 1 and 4 ± 1 s1). A
schematic for the different states along the peptide elongation path
is shown in Fig. 10. Rodnina and co-workers having identiﬁed up to
seven distinct steps on the pathway from initial binding of the
ternary complex to the peptidyl transfer [118,119] (see Fig. 10B).
This revised scheme includes initial binding and codon recognition
to bring the system to its ﬁrst selection point, where the off-rates
between forming the cognate and near-cognate ternary complexes
differ by a factor of up to 1000 [119,120]. This leads to GTPase
activation and rate-limiting GTP hydrolysis, which is rate-limiting
for the non-cognate complexes but not for the cognate complexes
[119,120], and a proofreading step in which the aa-tRNA can either
continue to form the peptide bond or be rejected with unequal
probabilities for correct and incorrect substrates.
Additional major breakthroughs in this area came in 2009 and
2010 [20,110], with the elucidation of medium-resolution (3.2 Å)
crystal structures of EF-Tu in complex with the ribosome. In par-
ticular, the resulting structure showed His84 as being positioned
in an apparently ideal position to accept a proton from the nucle-
ophilic water molecule (Fig. 3B), causing the authors to proposepathway illustrating the delivery of tRNA in a ternary complex between EF-Tu and
al A-site (yielding the A/A conformation). The insets show structural changes of the
e the ribosomal ‘‘ON’’ and ‘‘OFF’’ states. (B) Overview of the main steps from tRNA
(for details see the main text). This ﬁgure was reproduced with permission from Ref.
Fig. 11. Different mechanistic possibilities for GTP hydrolysis by EF-Tu. (A) Base catalyzed hydrolysis by His84. (B) Proton transfer to the substrate with protonated His84
stabilizing the TS structure. (C) Proton transfer from His84 to the substrate mediated by the nucleophilic water molecule, followed by proton abstraction by the now neutral
His84. For simplicity all the mechanism are depicted as following a concerted SN2-like ANDN pathway, although as referred before they can also follow an associative or
dissociative pathway. For further details, see the main text.
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tion of GTP hydrolysis on the ribosome as a general base catalyst
(see Fig. 11 for a summary of currently popular mechanistic pro-
posals). It should be noted here that the catalytic center of
trGTPases, and, in particular, the histidine residue of the invariant
PGH motif in their active sites is strongly conserved [36,49,56,121]
and, therefore, the translational GTPases are expected to operate
through a universal GTP hydrolysis mechanism. Following from
this, a mechanism such as that proposed by Voorhees et al. would
intuitively seem to be fully reasonable, in particular as Rodnina and
coworkers [29] have shown that mutation of His84 to an alanine
residue reduces the rate of GTP hydrolysis more than 106 fold.
The preceding steps are only slightly affected, suggesting that the
effect of His84 is in the catalytic step itself.
There are, however, a number of complications with this pro-
posal. The ﬁrst is the close proximity of His84 to several negatively
charged species (Fig. 3B), including the phosphate group from the
SRL loop, the highly charged polyphosphate, and the sidechain of
Asp21, which would lead one to believe that the imidazole side-
chain is most likely protonated. As would be expected, calculations
uniformly suggest an upshift of at least three units in the pKa of
this residue [33,35,37]. We also recently performed free energy
calculations to examine the energetic cost of ground state proton
transfer from the catalytic water to His84, and demonstrated that
this is strongly disfavored by 17.5 kcal/mol (compared to the pro-
cess in aqueous solution), as a result of electrostatic repulsion
between the resulting hydroxide ion and the negative charge on
the c-phosphate of the GTP [37]. Additionally, and as also pointed
out by Liljas et al. [32], careful examination of the EF-Tu active site
shows that the coordination geometry of the water molecule
would rather suggest that one of its water molecules is involved
in a H-bonding interaction with the backbone carbonyl group of
Thr61 (Fig. 3A), whereas the other is very close to one of the
non-bridging oxygens of the c-phosphate. Tying in with this, we
demonstrated that a ground state proton transfer from the water
molecule to the c-phosphate is favorable by 8.3 kcal/mol (com-
pared to the same process in aqueous solution) [89], and that once
the GTP is protonated, the active site seems optimally arranged to
stabilize the negative charge on the resulting hydroxide ion (Figs. 8
and 9). Finally, the fact that there is no experimentally observed
pH-dependence in the pH region where the imidazole sidechain
of His84 would normally be expected to ionize (6–8.5) [29] pro-
vides further evidence against a mechanism such as that shown
in Fig. 11A. Remarkably, our recent MD simulations [37] demon-
strated that interaction with the SRL appears to spontaneouslydrive His84 into an activated conformation for GTP hydrolysis
(Fig. 9), which is only attained if the simulations are performed
with His84 in its protonated form. Therefore, structural, biochemi-
cal and computational evidence strongly suggest that His84 is
positively charged by the time it has reached the active site.
An alternative to nucleophile activation by histidine is a sub-
strate-as-base mechanism such as that suggested for Ras GTPase
[81–83]. This can, in principle, involve either a concerted (ANDN)
or a stepwise (AN + DN) pathway, as shown in Fig. 4C and A. Such
a mechanism is supported by both computational work of
Adamczyk and Warshel [33] and by our recent ground state free
energy calculations [37]. In both cases, His84 plays an important
role in activation of GTP hydrolysis, whether through direct elec-
trostatic interactions as described above [37], or through indirect
(‘‘allosteric’’) interactions as proposed by Adamczyk and Warshel
[33]. In theory, the reaction could also proceed through a mecha-
nism such as that suggested by Aleksandrov and Field (Fig. 11C)
[35], which involves a scenario in which the protonated histidine
transfers a proton to the substrate via the nucleophilic water mole-
cule and then this water molecule attacks a monoanionic phos-
phate, with His84 acting as a general base to active the
nucleophile. Such a mechanism would in principle not be incom-
patible with the observed pH independence, even though it
involves very complex movement of protons. Finally, one can
always ask whether the substrate-assisted pathways occur through
direct deprotonation of the nucleophilic water molecule Fig. 5B or
via an intermediary water molecule that provides a bridge between
the nucleophile and non-bridging oxygen of the phosphate Fig. 5C
[34], or whether a general-base is necessary at all, as has been
argued for Ras GTPase [63]. For comparison, our recent calculations
on the uncatalyzed hydrolysis of phosphate monoester dianions
suggest that, for good leaving groups, such a dissociative solvent-
assisted pathway in which there is no deprotonation of the nucle-
ophile at the transition state is preferred over a substrate-assisted
associative pathway [73]. In the case of EF-Tu, both these mecha-
nisms would require the presence of at least one additional water
molecule in the EF-Tu active site, which there is no space to accom-
modate (see also Fig. 9).
As can be seen from the mechanistic options outlined above, as
with Ras GTPase, the mechanisms of GTP hydrolysis on the ribo-
some are highly complex and subject to extensive discussion. A
further complication to this mechanistic picture is the availability
of recent crystal structures of the GTP-bound forms of free eukary-
otic and archaeal EF-Tu homologs, which clearly show the presence
a monovalent cation between the b- and the c-phosphates of the
88 A.T.P. Carvalho et al. / Archives of Biochemistry and Biophysics 582 (2015) 80–90bound GTP [24]. This cation was not present in e.g. previous EF-Tu
structures [20,110], however, the authors argued that the GTP ana-
logs GDPCD or GDPNP analogs used in previous work disrupt the
ion coordination, which was why it was not observed [24].
Clearly, if this ion really exists in that position in the activated
state, it could potentially have major impact on the energetics of
the GTP hydrolysis and affect the postulated mechanism.
To explore this issue, we recently performed an exhaustive
analysis of different possible mechanisms for GTP hydrolysis in
EF-Tu on the ribosome [89]. These calculations support the pre-
viously suggested substrate-assisted pathway [20], and emphasize
that, for optimal catalysis, His84 has to be doubly protonated to
stabilize the negative charge developing on the water nucleophile
during the reaction. Examining the contributions of different resi-
dues to the calculated activation barrier (Fig. 12) also highlighted
the importance of key active site residues in assisting the charge
migration during the chemical reaction, with His84 and the PGH
backbone acting as a ‘‘pull’’ for the negative charge on the c-phos-
phate, whereas Asp24 acts as a ‘‘push’’ to repel the negative charge
in the same direction. Finally, Lys24 eventually stabilizes the ﬁnal
double negative charge on the resulting GDP (see Figs. 3B and 10
for positions of key residues). Tying in with this stabilization of
charge migration is an important structural change predicted in
our previous work [37], where we found a backbone ﬂip of the
PGH motif to accommodate the catalytic conﬁrmation stabilizing
the oxyanion hole shown in Fig. 9. This structural change has
now been experimentally conﬁrmed [21,22], and our more recent
study demonstrates that it is crucial for obtaining reliable energet-
ics [89].
In conclusion, from our recent work [89], we surmise that the
proton transfer is not the rate-limiting step, in agreement with
the kinetic isotope effect measurements of Rodnina and coworkers
[38]. Additionally, there is no indication of a signiﬁcant catalytic
effect due to the presence of a monocovalent metal ion near the
a and c-phosphate oxygens from either experimental (indepen-
dence of the rate on the K+ concentration [38]) or from our
computational results. Following from this, we also examinedFig. 12. Detailed overview of the apparently preferred mechanism for GTP hydrolysis by
the free energy contributions from key active site residues at the transition state and jus
outlined in [33]. All free energy contributions correspond to contributions from individu
backbone of the PGH motif.two key mutations: H84Q and D21A (see Fig. 3A for the position
of these residues). We ﬁnd that mutating H84 to Q most probably
changes the identity of the most feasible mechanism from the
hydroxide mechanism towards the neutral concerted water attack
(with an activation energy of 20 kcal/mol). In contrast, the D21A
mutation can affect the mechanism in two different ways, both
of them in quantitative agreement with the determined experi-
mental rates. Therefore, our hypothesis is that the absence of this
negatively charged residue disrupts the favorable movement of
charge observed in the wild type (WT) enzyme, making the proton
transfer from the water to the c-phosphate oxygen less favorable
and, consequently, raising the free energy barrier. Finally, removal
of the Asp21 can potentially lead to a drop in His84 pKa, rendering
this histidine neutral, making the concerted water attack the most
feasible mechanistic hypothesis.
Conclusions and future perspectives
GTPases are essential for many vital processes within the cell.
Their functions include controlling protein biosynthesis, growth
control, differentiation, cytoskeleton reorganization, and regulat-
ing transport processes. They act, for example, by regulating cell
signaling cascades, such as Ras, or by regulating transcription (in
the case of EF-Tu). In Ras and Ras related proteins the GTP bound
conformation is acting as a clock, while the switch is ‘‘ON’’ the
downstream cascade and subsequence cellular function is acti-
vated. In EF-Tu the GTP bound conformation it is working as a sen-
sor. GTP hydrolysis only takes place activation by the SRL and
movement of His84 towards the active site [20–23].
It is interesting how the cell uses this common and universal
switching mechanism to activate all these different GTPases, with
similar conformational changes between conserved loops within
these enzymes regulating GTP hydrolysis and consequently the
exchange between active and inactive conformations. The extre-
mely important role of the Ras proteins in cellular homeostasis is
highlighted by the plethora of oncogenic mutations related to them
[78]. EF-Tu has also been recently identiﬁed as a potential cancerEF-Tu, based on computational work presented in Ref. [89]. The upper panels show
t after the transition state, relative to the corresponding reacting state, obtained as
al amino acid sidechains, except for ‘‘PGH bb’’ which denotes interactions with the
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levels with various carcinomas [122–125]. All of these factors
make GTPases very attractive systems to study, both experimen-
tally and computationally. In fact, the history of the study of these
enzymes is very vast, although not free of controversy. A major
point of debate lies in the details of the GTP hydrolysis catalytic
mechanism and more speciﬁcally in the nature of the transition
state structure and associated base.
Most studies trying to tackle the mechanism of GTP hydrolysis
used either Ras [75,86,88,94,97–100] or Ras-related enzymes
[94,102] and EF-Tu [29,35,40,41] as model systems. Early studies
on these enzymes posited analogous hypotheses that nearby active
site residues, speciﬁcally the conserved Gln61/His84 residues in
Switch loop II would fulﬁll the role of a catalytic base. However,
these hypotheses were mostly discarded based on deeper analysis
of the pKas of these residues and in mutational and computational
studies [33,35,37,89]. The discussion then shifted to the nature of
the TS structure, where both associative [72,126] and dissociative
[93,97–102] transition states have been suggested based on how
the available experimental and computational data are predicted.
However, irrespective of the precise nature of the TS, we share
the view of Refs. [33,34,37,90,95,108] that the catalytic effect of
these enzymes is likely to be primarily electrostatic in nature,
and that mutations to active site residues would disrupt the perfect
balance in charge distribution these enzymes have evolved to
provide.
There is still a long road ahead in the study of GTPases.
Although there now exist detailed descriptions of the catalytic
mechanism of the WT enzymes [33,35,37,63,72,81,103], as well
as characterization of the effect of some mutations in atomic detail
[29,90,96,108], there still exist several oncogenic mutations [78]
that remain an open question in terms of the rationale behind their
deleterious effects. Therefore, there is plenty of scope for further
work in modeling these reactions, both focusing on the actual
chemical step of catalysis and also on large-scale conformational
dynamics and the effect of interactions with GEFs, GAP and effector
proteins, which becomes increasingly feasible to study with con-
stant advances in computational power.Acknowledgments
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